Overjet’s artificial intelligence has received its 4th FDA clearance, enabling clinicians to use it to detect and outline caries on both periapical and bitewing radiographs.
Overjet’s artificial intelligence (AI) technology has officially received its fourth United States Food and Drug Administration (FDA) clearance. This technology detects and outlines caries on periapical radiographs and bitewing radiographs, per a press release from Overjet.
Because Overjet utilizes its AI models to help inform treatment planning for dentists, this technology can be vital for both patient and practitioner. Overjet’s AI outlines decay, allowing clinicians to get a better view of caries in the patient’s mouth.
“Untreated cavities can lead to problems with eating, speaking, self-esteem, and quality of life,” Wardah Inam, CEO and co-founder of Overjet, says in the press release. “Our goal is to improve oral health care for all, and expanding Overjet’s AI detection capabilities give dentists another advantage to help provide the best care possible.”
Overjet’s AI is specifically designed to integrate with most practice management systems, allowing for a seamless transition into any dental practice. Using this AI, clinicians can also look at patient records from past appointments if need be. Overjet’s AI is also cleared by the FDA to detect calculus and quantify bone level measurements.